Edgar Filing: MEDICAL PROPERTIES TRUST INC

Large accelerated filer

x (Medical Properties Trust, Inc. only)

Accelerated filer

Non-accelerated filer

x (Do not check if a smaller reporting company)

Smaller reporting company

(MPT Operating Partnership, L.P. only)

10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2012

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-32559

MEDICAL PROPERTIES TRUST, INC.

MPT OPERATING PARTNERSHIP, L.P.

(Exact Name of Registrant as Specified in Its Charter)


MARYLAND DELAWARE		20-0191742 20-0242069
(State or other jurisdiction of incorporation or organization)		(I. R. S. Employer Identification No.)

1000 URBAN CENTER DRIVE, SUITE 501 BIRMINGHAM, AL		35242
(Address of principal executive offices)		(Zip Code)

REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE: (205) 969-3755

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of November 5, 2012, Medical Properties Trust, Inc. had 135,572,131 shares of common stock, par value $.001, outstanding.

EXPLANATORY NOTE

This report combines the Quarterly Reports on Form 10-Q for the three and nine months ended September 30, 2012 of Medical Properties Trust, Inc., a Maryland corporation, and MPT Operating Partnership, L.P., a Delaware limited partnership, through which Medical Properties Trust, Inc. conducts substantially all of its operations. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” “our company,” “Medical Properties,” “MPT,” or “the company” refer to Medical Properties Trust, Inc. together with its consolidated subsidiaries, including MPT Operating Partnership, L.P. Unless otherwise indicated or unless the context requires otherwise, all references to “our operating partnership” or “the operating partnership” refer to MPT Operating Partnership, L.P. together with its consolidated subsidiaries.

MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P.

AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED September 30, 2012

Table of Contents


	Page
PART I — FINANCIAL INFORMATION		4
Item 1 Financial Statements		4

Medical Properties Trust, Inc. and Subsidiaries		4
Condensed Consolidated Balance Sheets at September 30, 2012 and December 31, 2011		4
Condensed Consolidated Statements of Income for the Three Months and Nine Months Ended September 30, 2012 and 2011		5
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months and Nine Months Ended September 30, 2012 and 2011		6
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2012 and 2011		7
MPT Operating Partnership, L.P. and Subsidiaries		8
Condensed Consolidated Balance Sheets at September 30, 2012 and December 31, 2011		8
Condensed Consolidated Statements of Income for the Three Months and Nine Months Ended September 30, 2012 and 2011		9
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months and Nine Months Ended September 30, 2012 and 2011		10
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2012 and 2011		11

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P.		12
Notes to Condensed Consolidated Financial Statements		12
Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations		34
Item 3 Quantitative and Qualitative Disclosures about Market Risk		41
Item 4 Controls and Procedures		42
PART II — OTHER INFORMATION		42
Item 1 Legal Proceedings		42
Item 1A Risk Factors		42
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds		43
Item 3 Defaults Upon Senior Securities		43
Item 4 Mine Safety Disclosures		43
Item 5 Other Information		44
Item 6 Exhibits		44
SIGNATURE		45
INDEX TO EXHIBITS		46

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements.

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets


	September 30, 2012			December 31, 2011
(In thousands, except per share amounts)	(Unaudited)			(Note 2)
Assets
Real estate assets
Land, buildings and improvements, and intangible lease assets	$	1,251,909		$	1,217,559
Real estate held for sale		17,432			48,925
Mortgage loans		368,650			165,000
Net investment in direct financing leases		312,050			—

Gross investment in real estate assets		1,950,041			1,431,484
Accumulated depreciation and amortization		(120,215	)		(94,822	)

Net investment in real estate assets		1,829,826			1,336,662
Cash and cash equivalents		36,163			102,726
Interest and rent receivable		42,094			29,862
Straight-line rent receivable		38,065			33,993
Other loans		158,177			74,839
Other assets		54,074			43,792

Total Assets	$	2,158,399		$	1,621,874

Liabilities and Equity
Liabilities
Debt, net	$	1,025,183		$	689,849
Accounts payable and accrued expenses		64,297			51,125
Deferred revenue		20,374			23,307
Lease deposits and other obligations to tenants		15,387			28,778

Total liabilities		1,125,241			793,059
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding		—			—
Common stock, $0.001 par value. Authorized 250,000 shares; issued and outstanding — 134,657 shares at September 30, 2012, and 110,786 shares at December 31, 2011		135			111
Additional paid in capital		1,280,769			1,055,256
Distributions in excess of net income		(234,264	)		(214,059	)
Accumulated other comprehensive loss		(13,220	)		(12,231	)
Treasury shares, at cost		(262	)		(262	)

Total equity		1,033,158			828,815

Total Liabilities and Equity	$	2,158,399		$	1,621,874

See accompanying notes to condensed consolidated financial statements.

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(Unaudited)


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In thousands, except per share amounts)	2012			2011			2012			2011
Revenues
Rent billed	$	31,083		$	27,760		$	93,100		$	81,086
Straight-line rent		2,762			1,643			5,473			5,318
Income from direct financing leases		5,773			—			12,979			—
Interest and fee income		14,037			5,229			33,486			15,714

Total revenues		53,655			34,632			145,038			102,118
Expenses
Real estate depreciation and amortization		8,491			7,700			25,392			22,508
Property-related		218			260			1,044			346
General and administrative		7,052			5,737			21,341			20,429
Acquisition expenses		410			530			4,115			3,186

Total operating expenses		16,171			14,227			51,892			46,469

Operating income		37,484			20,405			93,146			55,649
Other income (expense)
Interest and other (expense) income		(23	)		42			(55	)		(12	)
Earnings from equity and other interests		1,065			9			1,944			70
Debt refinancing costs		—			(10,425	)		—			(14,214	)
Interest expense		(15,046	)		(11,935	)		(42,730	)		(32,462	)

Net other expense		(14,004	)		(22,309	)		(40,841	)		(46,618	)

Income (loss) from continuing operations		23,480			(1,904	)		52,305			9,031
Income from discontinued operations		8,028			2,372			9,169			4,944

Net income		31,508			468			61,474			13,975
Net income attributable to non-controlling interests		(44	)		(43	)		(130	)		(131	)

Net income attributable to MPT common stockholders	$	31,464		$	425		$	61,344		$	13,844

Earnings per common share — basic and diluted
Income (loss) from continuing operations attributable to MPT common stockholders	$	0.17		$	(0.02	)	$	0.39		$	0.07
Income from discontinued operations attributable to MPT common stockholders		0.06			0.02			0.07			0.05

Net income attributable to MPT common stockholders	$	0.23		$	—		$	0.46		$	0.12

Weighted average shares outstanding:
Basic		134,781			110,714			131,467			110,568
Diluted		134,782			110,719			131,467			110,576

Dividends declared per common share	$	0.20		$	0.20		$	0.60		$	0.60

See accompanying notes to condensed consolidated financial statements.

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In thousands)	2012			2011			2012			2011

Net income	$	31,508		$	468		$	61,474		$	13,975
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(443	)		(5,272	)		(989	)		(8,341	)

Total comprehensive income (loss)		31,065			(4,804	)		60,485			5,634
Comprehensive income attributable to non-controlling interests		(44	)		(43	)		(130	)		(131	)

Comprehensive income (loss) attributable to MPT common stockholders	$	31,021		$	(4,847	)	$	60,355		$	5,503

See accompanying notes to condensed consolidated financial statements.

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)


	For the Nine Months Ended September 30,
	2012			2011
	(In thousands)
Operating activities
Net income	$	61,474		$	13,975
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization		26,899			25,254
Straight-line rent revenue (net of write-offs)		(4,100	)		(5,606	)
Direct financing lease interest accretion		(2,050	)		—
Share-based compensation		5,430			5,293
(Gain) loss on sale of real estate		(7,278	)		(5	)
Real estate impairment		—			564
Amortization and write-off of deferred financing costs and debt discount		2,577			8,523
Premium paid on extinguishment of debt		—			13,091
Other adjustments		(3,415	)		(4,632	)
Changes in:
Interest and rent receivable		(12,232	)		(2,646	)
Accounts payable and accrued expenses		7,404			13,317

Net cash provided by operating activities		74,709			67,128
Investing activities
Cash paid for acquisitions and other related investments		(606,500	)		(208,913	)
Principal received on loans receivable		9,507			2,898
Net proceeds from sale of real estate		34,100			—
Investment in loans receivable		(1,293	)		(4,398	)
Construction in progress and other		(35,920	)		(12,297	)

Net cash used for investing activities		(600,106	)		(222,710	)
Financing activities
Revolving credit facilities, net		35,400			39,600
Additions to term debt		300,000			450,000
Payments of term debt		(171	)		(237,810	)
Distributions paid		(76,770	)		(67,194	)
Sale of common stock, net		220,107			—
Lease deposits and other obligations to tenants		(13,391	)		7,613
Debt issuance costs paid and other financing activities		(6,341	)		(20,667	)

Net cash provided by financing activities		458,834			171,542

Increase (decrease) in cash and cash equivalents for period		(66,563	)		15,960
Cash and cash equivalents at beginning of period		102,726			98,408

Cash and cash equivalents at end of period	$	36,163		$	114,368

Interest paid	$	31,350		$	18,761
Supplemental schedule of non-cash investing activities:
Loan conversion to equity interest	$	1,648		$	—
Real estate acquired via assumption of mortgage loan		—		$	(14,592	)
Mortgage loan issued from sale of real estate	$	3,650			—
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	$	27,181		$	22,407
Assumption of mortgage loan (as part of real estate acquired)		—		$	14,592

See accompanying notes to condensed consolidated financial statements.

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets


	September 30, 2012			December 31, 2011
(In thousands)	(Unaudited)			(Note 2)
Assets
Real estate assets
Land, buildings and improvements, and intangible lease assets	$	1,251,909		$	1,217,559
Real estate held for sale		17,432			48,925
Mortgage loans		368,650			165,000
Net investment in direct financing leases		312,050			—

Gross investment in real estate assets		1,950,041			1,431,484
Accumulated depreciation and amortization		(120,215	)		(94,822	)

Net investment in real estate assets		1,829,826			1,336,662
Cash and cash equivalents		36,163			102,726
Interest and rent receivable		42,094			29,862
Straight-line rent receivable		38,065			33,993
Other loans		158,177			74,839
Other assets		54,074			43,792

Total Assets	$	2,158,399		$	1,621,874

Liabilities and Capital
Liabilities
Debt, net	$	1,025,183		$	689,849
Accounts payable and accrued expenses		37,157			28,780
Deferred revenue		20,374			23,307
Lease deposits and other obligations to tenants		15,387			28,778
Payable due to Medical Properties Trust, Inc.		26,750			21,955

Total liabilities		1,124,851			792,669
Capital
General Partner — issued and outstanding — 1,345 units at September 30, 2012 and 1,107 units at December 31, 2011		10,431			8,418
Limited Partners:
Common units — issued and outstanding — 133,312 units at September 30, 2012 and 109,679 units at December 31, 2011		1,036,337			833,018
LTIP units — issued and outstanding — 150 units at September 30, 2012 and at December 31, 2011		—			—
Accumulated other comprehensive loss		(13,220	)		(12,231	)

Total capital		1,033,548			829,205

Total Liabilities and Capital	$	2,158,399		$	1,621,874

See accompanying notes to condensed consolidated financial statements.

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(Unaudited)


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In thousands, except per unit amounts)	2012			2011			2012			2011
Revenues
Rent billed	$	31,083		$	27,760		$	93,100		$	81,086
Straight-line rent		2,762			1,643			5,473			5,318
Income from direct financing leases		5,773			—			12,979			—
Interest and fee income		14,037			5,229			33,486			15,714

Total revenues		53,655			34,632			145,038			102,118
Expenses
Real estate depreciation and amortization		8,491			7,700			25,392			22,508
Property-related		218			260			1,044			346
General and administrative		7,052			5,719			21,341			20,367
Acquisition expenses		410			530			4,115			3,186

Total operating expenses		16,171			14,209			51,892			46,407

Operating income		37,484			20,423			93,146			55,711
Other income (expense)
Interest and other income (expense)		(23	)		42			(55	)		(12	)
Earnings from equity and other interests		1,065			9			1,944			70
Debt refinancing costs		—			(10,425	)		—			(14,214	)
Interest expense		(15,046	)		(11,935	)		(42,730	)		(32,462	)

Net other expense		(14,004	)		(22,309	)		(40,841	)		(46,618	)

Income (loss) from continuing operations		23,480			(1,886	)		52,305			9,093
Income from discontinued operations		8,028			2,372			9,169			4,944

Net income		31,508			486			61,474			14,037
Net income attributable to non-controlling interests		(44	)		(43	)		(130	)		(131	)

Net income attributable to MPT Operating Partnership partners	$	31,464		$	443		$	61,344		$	13,906

Earnings per units — basic and diluted
Income (loss) from continuing operations attributable to MPT Operating Partnership partners	$	0.17		$	(0.02	)	$	0.39		$	0.07
Income from discontinued operations attributable to MPT Operating Partnership partners		0.06			0.02			0.07			0.05

Net income attributable to MPT Operating Partnership Partners	$	0.23		$	—		$	0.46		$	0.12

Weighted average units outstanding:
Basic		134,781			110,714			131,467			110,568
Diluted		134,782			110,719			131,467			110,576
Dividends declared per unit	$	0.20		$	0.20		$	0.60		$	0.60

See accompanying notes to condensed consolidated financial statements.

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
(In thousands)	2012			2011			2012			2011

Net income	$	31,508		$	486		$	61,474		$	14,037
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(443	)		(5,272	)		(989	)		(8,341	)

Total comprehensive income (loss)		31,065			(4,786	)		60,485			5,696
Comprehensive income attributable to non-controlling interests		(44	)		(43	)		(130	)		(131	)

Comprehensive income (loss) attributable to MPT Operating Partnership partners	$	31,021		$	(4,829	)	$	60,355		$	5,565

See accompanying notes to condensed consolidated financial statements.

MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Unaudited)


	For the Nine Months Ended September 30,
	2012			2011
	(In thousands)
Operating activities
Net income	$	61,474		$	14,037
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization		26,899			25,254
Straight-line rent revenue (net of write-offs)		(4,100	)		(5,606	)
Direct financing lease interest accretion		(2,050	)		—
Share-based compensation		5,430			5,293
(Gain) loss on sale of real estate		(7,278	)		(5	)
Real estate impairment		—			564
Amortization and write-off of deferred financing costs and debt discount		2,577			8,523
Premium paid on extinguishment of debt		—			13,091
Other adjustments		(3,415	)		(4,694	)
Changes in:
Interest and rent receivable		(12,232	)		(2,646	)
Accounts payable and accrued expenses		7,404			13,317

Net cash provided by operating activities		74,709			67,128
Investing activities
Cash paid for acquisitions and other related investments		(606,500	)		(208,913	)
Principal received on loans receivable		9,507			2,898
Net proceeds from sale of real estate		34,100			—
Investment in loans receivable		(1,293	)		(4,398	)
Construction in progress and other		(35,920	)		(12,297	)

Net cash used for investing activities		(600,106	)		(222,710	)
Financing activities
Revolving credit facilities, net		35,400			39,600
Additions to term debt		300,000			450,000
Payments of term debt		(171	)		(237,810	)
Distributions paid		(76,770	)		(67,194	)
Sale of common stock, net		220,107			—
Lease deposits and other obligations to tenants		(13,391	)		7,613
Debt issuance costs paid and other financing activities		(6,341	)		(20,667	)

Net cash provided by financing activities		458,834			171,542

Increase (decrease) in cash and cash equivalents for period		(66,563	)		15,960
Cash and cash equivalents at beginning of period		102,726			98,408

Cash and cash equivalents at end of period	$	36,163		$	114,368

Interest paid	$	31,350		$	18,761
Supplemental schedule of non-cash investing activities:
Loan conversion to equity interest	$	1,648		$	—
Real estate acquired via assumption of mortgage loan		—		$	(14,592	)
Mortgage loan issued from sale of real estate	$	3,650			—
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	$	27,181		$	22,407
Assumption of mortgage loan (as part of real estate acquired)		—		$	14,592

See accompanying notes to condensed consolidated financial statements.

MEDICAL PROPERTIES TRUST, INC., AND MPT OPERATING PARTNERSHIP, L.P.

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Organization

Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003 under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist.

We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRSs”). Our TRSs are subject to both federal and state income taxes.

Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment.

2. Summary of Significant Accounting Policies

Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended September 30, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012. The condensed consolidated balance sheet at December 31, 2011 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K, as amended, for the year ended December 31, 2011. During the three and nine months ended September 30, 2012, there were no material changes to these policies, except we began using direct financing lease (“DFL”) accounting with the acquisition and lease of the real estate of Ernest Health, Inc. (“Ernest”) and the acquisition and lease of two acute care hospitals to Prime Healthcare Services, Inc. (“Prime”). Under DFL accounting, future minimum lease payments are recorded as a receivable. Unearned income, which represents the net investment in the DFL less the sum of minimum lease payments receivable and the estimated residual values of the leased properties, is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unamortized and unearned income. DFLs are placed on non-accrual status when management determines that the collectability of contractual amounts is not reasonably assured. While on non-accrual status, DFLs are accounted for on a cash basis, in which income is recognized only upon receipt of cash.

For our equity interest in Ernest and related loans (as more fully described in Note 3), we have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans made in or prior to 2012.

Variable Interest Entities

In regard to the Ernest Transaction (defined in Note 3), we have determined that Ernest is a variable interest entity (“VIE”); however, we are not the primary beneficiary as we lack the ability to direct the activities of Ernest that most significantly impact the entity’s economic performance. At September 30, 2012, we had loans to and/or equity investments in several VIEs for which we are not the primary beneficiary. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at September 30, 2012 (in thousands):


VIE Type	Maximum Loss Exposure(1)		Asset Type Classification	Carrying Amount(2)
Loans, net	$	274,073	Mortgage and other loans	$	230,105
Equity investments	$	13,764	Other assets	$	3,179

(1)

Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrowers or investees) that most significantly impact the VIE’s economic performance. As of September 30, 2012, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).

Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

3. Real Estate and Lending Activities

Acquisitions

2012 Activity

On September 19, 2012, we acquired the real estate of the 380 bed St. Mary’s Regional Medical Center, an acute care hospital in Reno, Nevada for $80 million and the real estate of the 140 bed Roxborough Memorial Hospital in Pennsylvania for $30 million. The acquired facilities are leased to Prime pursuant to a master lease agreement, which is more fully described below in the Leasing Operations section.

On July 3, 2012, we funded a $100 million mortgage loan secured by the real property of Centinela Hospital Medical Center. Centinela is a 369 bed acute care facility that is operated by Prime. This mortgage loan is cross-defaulted with other mortgage loans to Prime and the master lease agreements.

On February 29, 2012, we made loans to and acquired assets from Ernest for a combined purchase price and investment of $396.5 million, consisting of $200 million to purchase real estate assets, a first mortgage loan of $100 million, an acquisition loan for $93.2 million and a capital contribution of $3.3 million (“Ernest Transaction”).

Real Estate Acquisition and Mortgage Loan Financing

Pursuant to a definitive real property asset purchase agreement (the “Purchase Agreement”), we acquired from Ernest and certain of its subsidiaries (i) a portfolio of five rehabilitation facilities (including a ground lease interest relating to a community-based acute rehabilitation facility in Wyoming), (ii) seven long-term acute care facilities located in seven states and (iii) undeveloped land in Provo, Utah (collectively, the “Acquired Facilities”) for an aggregate purchase price of $200 million, subject to certain adjustments. The Acquired Facilities are leased to subsidiaries of Ernest pursuant to a master lease agreement. The master lease agreement has a 20-year term with three five-year extension options and provides for an initial rental rate of 9%, with consumer price-indexed increases, limited to a 2% floor and 5% ceiling annually thereafter. In addition, we made Ernest a $100 million loan secured by a first mortgage interest in four subsidiaries of Ernest, which has terms similar to the leasing terms described above.

Acquisition Loan and Equity Contribution

Through an affiliate of one of our TRSs, we made investments of approximately $96.5 million in Ernest Health Holdings, LLC (“Ernest Holdings”), which is the owner of Ernest. These investments, which are structured as a $93.2 million loan and a $3.3 million equity contribution generally provide that we will receive a preferential return of 15% of the loan amount and approximately 79% of

the remaining earnings of Ernest. Ernest is required to pay us a minimum of 6% and 7% of the loan amount in years one and two, respectively, and 10% thereafter, although there are provisions in the loan agreement that are expected to result in full payment of the 15% preference when funds are sufficient. Any of the 15% in excess of the minimum that is not paid may be accrued and paid upon the occurrence of a capital or liquidity event and is payable at maturity. The loan may be prepaid without penalty at any time.

Financing of Ernest Transaction

To finance the Ernest Transaction, we completed equity and senior unsecured notes offerings in February 2012. See Notes 4 and 5 for more information on these financing activities.

2011 Activity

On January 4, 2011, we acquired the real estate of the 19-bed, 4-year old Gilbert Hospital in a suburb of Phoenix, Arizona area for $17.1 million. Gilbert Hospital is operated by affiliates of Visionary Health, LLC. We acquired this asset subject to an existing lease that expires in May 2022.

On January 31, 2011, we acquired for $23.5 million the real estate of the 60-bed Atrium Medical Center at Corinth in the Dallas area, a long-term acute care hospital that was completed in 2009 and is subject to a lease that expires in June 2024. In addition, through one of our affiliates, we invested $1.3 million to acquire approximately 19% of a joint venture arrangement with an affiliate of Vibra Healthcare, LLC (“Vibra”) that will manage and has acquired a 51% interest in the operations of the facility. We also made a $5.2 million working capital loan to the joint venture. The former operators of the hospital, comprised primarily of local physicians, retained ownership of 49% of the operating entity.

On February 4, 2011, we purchased for $58 million the real estate of Bayonne Medical Center, a 6-story, 278-bed acute care hospital in the New Jersey area of metropolitan New York, and leased the facility to the operator under a 15-year lease, with six 5-year extension options. The operator is an affiliate of a private hospital operating company that acquired the hospital in 2008.

On February 9, 2011, we acquired the real estate of the 306-bed Alvarado Hospital in San Diego, California for $70 million from Prime who is the operator of the facility.

On February 14, 2011, we completed the acquisition of the Northland LTACH Hospital located in Kansas City, a 35-bed hospital that opened in April 2008 and has a lease that expires in 2028. This hospital is currently being operated by Kindred Healthcare Inc. The purchase price of this hospital was $19.5 million, which included the assumption of a mortgage loan.

On July 18, 2011, we acquired the real estate of the 40-bed Vibra Specialty Hospital of DeSoto in Desoto, Texas for $13.0 million. Vibra Specialty Hospital of DeSoto is a long-term acute care hospital. This facility is leased to a subsidiary of Vibra for a fixed term of 15 years with options to extend. In addition, we made a $2.5 million equity investment in the operator of this facility for a 25% equity ownership.

On September 30, 2011, we purchased the real estate of a 40-bed long-term acute care facility in New Braunfels, Texas for $10.0 million. This facility is leased to an affiliate of Post Acute Medical, LLC for a fixed term of 15 years with options to extend. In addition, we made a $1.4 million equity investment for a 25% equity ownership in the operator of this facility and funded a $2.0 million working capital loan.

As part of these acquisitions, we purchased and invested in the following assets during the first nine months: (dollar amounts in thousands)


	2012		2011
Assets Acquired
Land	$	—	$	17,218
Building		—		178,535
Intangible lease assets — subject to amortization (weighted average useful life of 13.5 years in 2011)		—		15,351
Net investments in direct financing leases		310,000		—
Mortgage loans		200,000		—
Other loans		93,200		7,233
Equity investments		3,300		5,168

Total assets acquired	$	606,500	$	223,505
Total liabilities assumed		—		(14,592	)

Net assets acquired	$	606,500	$	208,913

From the respective acquisition dates, the properties and mortgage loans acquired in 2012 contributed $14.1 million and $29.1 million of revenue and income (excluding related acquisition expenses) for the three and nine month periods ended September 30, 2012, respectively. In addition, we incurred $0.1 million and $3.8 million of acquisition related costs on the 2012 acquisitions for the three and nine months ended September 30, 2012.

From the respective acquisition dates, the seven hospitals acquired in 2011 contributed $5.5 million and $14.0 million of revenue and $3.7 million and $9.1 million of income (excluding related acquisition expenses) for the three and nine months ended September 30, 2011, respectively. In addition, we incurred $0.5 million and $3.2 million of acquisition related costs on consummated and non-consummated deals for the three and nine months ended September 30, 2011.

The results of operations for each of the properties acquired are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2012 and 2011, as if each acquisition in 2012 and 2011 were consummated on the same terms at the beginning of 2011. Supplemental pro forma earnings were adjusted to exclude acquisition-related costs on consummated deals incurred in the three and nine months ended September 30, 2012 and 2011 (dollar amounts in thousands except per share/unit data).


	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2012		2011		2012		2011
Total revenues	$	56,557	$	53,943	$	166,952	$	162,593
Net income		33,834		13,846		82,822		56,733
Net income per share/unit — diluted	$	0.25	$	0.10	$	0.61	$	0.42

Development Activities

On June 13, 2012, we entered into an agreement with Ernest to develop and lease a 40-bed rehabilitation hospital in Lafayette, Indiana. Total development cost is estimated to be $16.6 million and the facility is expected to be completed in the 2013 second quarter. We have funded $7.2 million through the third quarter of 2012.

On May 4, 2012, we amended the current lease on our Victoria, Texas facility with Post Acute Medical to extend the current lease term into 2028, and we agreed to develop and lease a 26-bed facility next to the current facility. Total development cost of the new facility is estimated to be $9.4 million and it is expected to be completed in the third quarter of 2013.

On March 1, 2012, we received a certificate of occupancy for our recently constructed Florence acute care facility near Phoenix, Arizona. With this, we started recognizing rent on this facility in March 2012. During the construction period, we accrued and deferred rent based on the cost paid during the construction period. In March 2012, we began recognizing a portion of the accrued construction period rent along with interest on the unpaid amount. This accrued construction period rent will be recognized in our income statement and paid over the 25 year lease term. Land and building costs associated with this property approximates $30 million.

In addition to the new development projects, our other three development projects, which will be leased to Emerus Holding, Inc., are expected to be completed between October 2012 and early 2013. Estimated total development cost for these three facilities is $30 million. We have funded $17.6 million through the third quarter of 2012. In regard to our River Oaks facility, re-development efforts continue and we currently expect this facility to be partially occupied starting in the first quarter of 2013.

Disposals

During the third quarter of 2012, we entered into a definitive agreement to sell the real estate of two LTACH facilities, Thornton and New Bedford, to Vibra for total cash proceeds of $42 million. The sale of Thornton was completed on September 28, 2012, resulting in a gain of $8.4 million. Due to this sale, we wrote-off $1.6 million in straight-line rent receivables. The sale of New Bedford was completed on October 22, 2012, resulting in a gain of approximately $7.0 million. Associated with this sale, we will write-off $4.1 million in straight-line rent receivables in the fourth quarter 2012. At September 30, 2012, our New Bedford facility is classified as held for sale, which required us to reclassify the operating results of this facility for the current and all prior periods to discontinued operations and reclassify the related real estate to Real Estate Held for Sale.

On August 21, 2012, we sold our Denham Springs facility for $5.2 million, resulting in a gain of $0.3 million. Due to this sale, the operating results of this facility for the current and all prior periods have been included in discontinued operations, and we have reclassified the related real estate to Real Estate Held for Sale.

On June 15, 2012, we sold the HealthSouth Rehabilitation Hospital of Fayetteville in Fayetteville, Arkansas for $16 million, resulting in a loss of $1.4 million. Due to this sale, the operating results of this facility for the current and all prior periods have been included in discontinued operations, and we have reclassified the related real estate to Real Estate Held for Sale. In connection with this sale, HealthSouth Corporation agreed to extend the lease on our Wichita, Kansas property, which is now set to end in March 2022.

Leasing Operations

On July 3, 2012, we entered into master lease agreements with certain subsidiaries of Prime, which replaced the then current leases with the same tenants covering the same properties. The master leases are for 10 years and contain two renewal options of five years each. The initial lease rate is generally consistent with the blended average rate of the prior lease agreements. However, the annual escalators, which in the prior leases were limited, have been increased to reflect 100% of CPI increases, along with a minimum floor. The master leases include repurchase options substantially similar to those in the prior leases, including provisions establishing minimum repurchase prices equal to our total investment.

As noted previously, we are accounting for the master lease of 12 Ernest facilities and our Roxborough and Reno facilities as a DFL. The components of our net investment in DFL consisted of the following (dollars in thousands):


	As of September 30, 2012
Minimum lease payments receivable	$	1,279,818
Estimated residual values		200,000
Less unearned income		(1,167,768	)

Net investment in direct financing leases	$	312,050

Monroe facility

As of September 30, 2012, we have advanced $29.9 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana pursuant to a working capital loan agreement, but no additional advances were made during the 2012 third quarter. In addition, as of September 30, 2012, we have $19.0 million of rent, interest and other charges owed to us by the operator, of which $5.8 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During 2010, we recorded a $12 million impairment charge on the working capital loan and recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. We have not recognized any interest income on the Monroe loan since it was considered impaired and have not recorded any unbilled rent since 2010.

At September 30, 2012, our net investment (exclusive of the related real estate) of approximately $37 million is our maximum exposure to Monroe and the amount is deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in approximately (i) $5 million in hospital patient receivables, (ii) cash balances of approximately $0.1 million, (iii) our assessment of the realizable value of our other collateral and (iv) continued improvement in operational revenue statistics compared to previous years. However, no assurances can be made that we will not have additional charges for further impairment of our working capital loan in the future.

On September 4, 2012, Monroe Hospital entered into a four-year agreement with St. Vincent Health, Inc. whereby St. Vincent will manage the operations of the hospital. At the same time we agreed with St. Vincent to exclusively negotiate the terms of a possible sale or lease of the hospital real estate by the end of such four year term. St. Vincent is a member of Ascension Health, the largest Catholic health care system in the country. However, there is no assurance that we will reach a satisfactory agreement with St. Vincent and St. Vincent has certain rights to terminate the management agreement during the four year term.

Other Loan Activity

On March 1, 2012, pursuant to our convertible note agreement, we converted $1.6 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At September 30, 2012, $3.4 million remains outstanding on the convertible note, and we retain the option, through November 2014, to convert this remainder into a 15.1% of equity interest in the operator.

Concentrations of Credit Risk

For the three and nine months ended September 30, 2012, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 20.8% and 18.1%, respectively, of total revenue. However, from an investment concentration perspective, Ernest represented 18.4% of our total assets at September 30, 2012.

For the three months ended September 30, 2012 and 2011, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 28.9% and 31.9%, respectively, of total revenue. For the nine months ended September 30, 2012 and 2011, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 26.3% and 31.7%, respectively, of total revenue. However, from an investment concentration perspective, Prime represented 28.7% and 25.3% of our total assets at September 30, 2012 and December 31, 2011, respectively.

On an individual property basis, we had no investment of any single property greater than 5% of our total assets as of September 30, 2012.

From a geographic perspective, all of our properties are located in the United States with 25.9% of our total assets at September 30, 2012 located in California.

4. Debt

The following is a summary of debt, net of discounts (dollar amounts in thousands):


	As of September 30, 2012						As of December 31, 2011
	Balance			Interest Rate			Balance			Interest Rate
Revolving credit facilities (A)	$	125,000			Variable		$	89,600			Variable
2006 Senior Unsecured Notes		125,000			Various			125,000			Various
2011 Senior Unsecured Notes		450,000			6.875	%		450,000			6.875	%
2012 Senior Unsecured Notes		200,000			6.375	%		—
Exchangeable senior notes:
Principal amount		11,000			9.250	%		11,000			9.250	%
Unamortized discount		(75	)					(180	)

		10,925						10,820
Term loans		114,258			Various			14,429			6.200	%

	$	1,025,183					$	689,849

(A)	Our $42 million collateralized revolving credit facility expired in June 2012.

As of September 30, 2012, principal payments due for our debt (which exclude the effects of any discounts recorded) are as follows (in thousands):


2012	$	61
2013		11,249
2014		265
2015		125,283
2016		225,299
Thereafter		663,101

Total	$	1,025,258

To help fund the 2012 acquisitions disclosed in Note 3, on February 17, 2012, we completed a $200 million offering of senior unsecured notes (“2012 Senior Unsecured Notes”), resulting in net proceeds, after underwriting discount, of $196.5 million. These 2012 senior unsecured notes accrue interest at a fixed rate of 6.375% per year and mature on February 15, 2022. The 2012 Senior Unsecured Notes include covenants substantially consistent with our 2011 Senior Unsecured Notes.

In addition, on March 9, 2012, we closed on a $100 million senior unsecured term loan facility (“2012 Term Loan”) and exercised the $70 million accordion feature on our revolving credit facility, increasing its capacity from $330 million to $400 million ($125.0 million outstanding at September 30, 2012). The 2012 Term Loan facility has an interest rate option of (1) LIBOR plus an initial spread of 2.25% or (2) the higher of the “prime rate”, federal funds rate plus 0.5%, or Eurodollar rate plus 1.0%, plus an initial spread of 1.25%. The 2012 Term Loan facility is scheduled to mature on March 9, 2016, but we have the option to extend the facility one year to March 9, 2017.

During the second quarter 2010, we entered into an interest rate swap to fix $65 million of our 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. At September 30, 2012 and December 31, 2011, the fair value of the interest rate swaps was $13.2 million and $12.2 million, respectively, which is reflected in accounts payable and accrued expenses on the condensed consolidated balance sheets.

We designated our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effect earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness in the periods; therefore, there was no income statement effect recorded during the three and nine month periods ended September 30, 2012 or 2011. We do not expect any of the current losses included in accumulated other comprehensive loss to be reclassified into earnings in the next 12 months. At September 30, 2012 and December 31, 2011, we had $6.7 million and $6.3 million, respectively, posted as collateral, which is currently reflected in other assets on our consolidated balance sheets.

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our revolving credit facility and 2012 Term Loan limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis. Through the quarter ending June 30, the dividend restriction was 115% of normalized adjusted FFO. Thereafter, a similar dividend restriction exists but the percentage drops each quarter (110% for quarter ending September 30, 2012) until reaching 95% at September 30, 2013. The indentures governing our 2011 and 2012 Senior Unsecured Notes also limit the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our 2011 and 2012 Senior Unsecured Notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.

In addition to these restrictions, the revolving credit facility and 2012 Term Loan contain customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and borrowing base interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At September 30, 2012, we were in compliance with all such financial and operating covenants.

5. Common Stock/Partner’s Capital

Medical Properties Trust, Inc.

To help fund the 2012 acquisitions disclosed in Note 3, on February 7, 2012, we completed an offering of 23,575,000 shares of our common stock (including 3,075,000 shares sold pursuant to the exercise in full of the underwriters’ overallotment option) at a price of $9.75 per share, resulting in net proceeds (after underwriting discount) of $220.1 million.

MPT Operating Partnership, L.P.

At September 30, 2012, the Company has a 99.8% ownership interest in Operating Partnership with the remainder owned by three other partners, two of which are employees and one of which is a director. During the nine months ended September 30, 2012, the partnership issued 23,575,000 units in direct response to the common stock offering by Medical Properties Trust, Inc.

6. Stock Awards

Our Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the “Equity Incentive Plan”) authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,441,180 shares of common stock for awards under the Equity Incentive Plan for which 1,436,693 shares remain available for future stock awards as of September 30, 2012. We awarded the following during 2012 and 2011:

Time-based awards — We granted 275,464 and 292,803 shares in 2012 and 2011, respectively, of time-based restricted stock to management, independent directors, and certain employees (2011 only). These awards vest quarterly based on service, over three years, in equal amounts.

Performance-based awards — Our management team and certain employees (2011 only) were awarded 252,566 and 253,655 performance based awards in 2012 and 2011, respectively. These awards vest ratably over a three year period based on the achievement of certain total shareholder return measures, with a carry-back and carryforward provision through December 31, 2015 (for the 2011 awards) and December 31, 2016 (for the 2012 awards). Dividends on these awards are paid only upon achievement of the performance measures.

Multi-year Performance-based awards — We awarded 649,793 and 600,000 shares in 2012 and 2011, respectively, of multi-year performance-based awards to management and certain employees. These shares are subject to three-year cumulative performance hurdles based on total shareholder return. At the end of the third-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

7. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as

discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and working capital loans is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes and 2011 and 2012 Senior Unsecured Notes, using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our 2006 Senior Unsecured Notes, revolving credit facilities, and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be possible and may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands):


	September 30, 2012						December 31, 2011
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	42,094		$	34,166		$	29,862		$	22,866
Loans (1)		333,627			333,275			239,839			243,272
Debt, net		(1,025,183	)		(1,080,514	)		(689,849	)		(688,032	)

(1)	Excludes loans related to the Ernest Transaction since they are recorded at fair value and discussed below.

Items Measured at Fair Value on a Recurring Basis

As discussed in Note 2, our equity interest in Ernest and related loans are being measured at fair value on a recurring basis. At September 30, 2012, these amounts were as follows (in thousands):


Asset Type	Fair Value		Cost		Asset Type Classification
Mortgage loans	$	100,000	$	100,000	Mortgage loans
Acquisition loan		93,200		93,200	Other loans
Equity investments		3,300		3,300	Other assets

	$	196,500	$	196,500

Our mortgage loans with Ernest are recorded at fair value based on Level 3 inputs by discounting the estimated cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our acquisition loan and equity investments are recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate discount rates based on the risk profile of comparable companies. We classify these loans and equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to the absence of quoted market prices. For these cash flow models, our observable inputs include capitalization rates and market interest rates, and our unobservable input includes our adjustment for minority discount, which was 500 basis points at September 30, 2012.

For the quarter and nine month period ended September 30, 2012, we had no gains/losses from fair value adjustments in our income statement. However, we recorded $5.7 million and $13.5 million of interest on these loans during the three and nine months ended September 30, 2012, respectively.

8. Discontinued Operations

As disclosed in Note 3, we sold our Thornton facility in Colorado and our Denham Springs facility in Louisiana in the 2012 third quarter and our HealthSouth Rehabilitation Hospital of Fayetteville in Fayetteville, Arkansas during the 2012 second quarter. In addition, our New Bedford facility was sold in October 2012, and at September 30, 2012, we reclassified the New Bedford facility as held for sale.

On December 30, 2011, we sold Mountain View Regional Rehabilitation Hospital in Morgantown, West Virginia to HealthSouth Corporation for $21.1 million, resulting in a gain of $2.3 million. We also sold Sherman Oaks Hospital in Sherman Oaks, California to Prime, on December 30, 2011 for $20.0 million, resulting in a gain of $3.1 million. Due to this sale, we wrote-off $1.2 million in straight-line rent receivables.

The following table presents the results of discontinued operations, which include the revenue and expenses of the previously-owned facilities noted above, for the three and nine months ended September 30, 2012 and 2011 (dollar amounts in thousands except per share/unit amounts):


	For the Three Months Ended September 30,					For the Nine Months Ended September 30,
	2012			2011		2012		2011
Revenues	$	(342	)	$	3,159	$	3,455	$	7,820
Gain on sale		8,726			—		7,280		5
Income		8,028			2,372		9,169		4,944
Earnings per share/unit — diluted	$	0.06		$	0.02	$	0.07	$	0.05

9. Earnings Per Share/Common Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (in thousands):


	For the Three Months Ended September 30,
	2012			2011
Numerator:
Income (loss) from continuing operations	$	23,480		$	(1,904	)
Non-controlling interests’ share in continuing operations		(44	)		(43	)
Participating securities’ share in earnings		(225	)		(264	)

Income (loss) from continuing operations, less participating securities’ share in earnings		23,211			(2,211	)
Income from discontinued operations attributable to MPT common stockholders		8,028			2,372

Net income, less participating securities’ share in earnings	$	31,239		$	161


	For the Three Months Ended September 30,
	2012		2011
Denominator
Basic weighted-average common shares		134,781		110,714
Dilutive share options		1		5

Dilutive weighted-average common shares		134,782		110,719


	For the Nine Months Ended September 30,
	2012			2011
Numerator:
Income from continuing operations	$	52,305		$	9,031
Non-controlling interests’ share in continuing operations		(130	)		(131	)
Participating securities’ share in earnings		(715	)		(860	)

Income from continuing operations, less participating securities’ share in earnings		51,460			8,040
Income from discontinued operations attributable to MPT common stockholders		9,169			4,944

Net income, less participating securities’ share in earnings	$	60,629		$	12,984


	For the Nine Months Ended September 30,
	2012		2011
Denominator

Basic weighted-average common shares		131,467		110,568
Dilutive share options		—		8

Dilutive weighted-average common shares		131,467		110,576

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (amounts in thousands):


	For the Three Months Ended September 30,
	2012			2011
Numerator:
Income (loss) from continuing operations	$	23,480		$	(1,886	)
Non-controlling interests’ share in continuing operations		(44	)		(43	)
Participating securities’ share in earnings		(225	)		(264	)

Income (loss) from continuing operations, less participating securities’ share in earnings		23,211			(2,193	)
Income from discontinued operations attributable to MPT Operating Partnership partners		8,028			2,372

Net income, less participating securities’ share in earnings	$	31,239		$	179


Denominator
Basic weighted-average units		134,781			110,714
Dilutive options		1			5

Dilutive weighted-average units		134,782			110,719


	For the Nine Months Ended September 30,
	2012			2011
Numerator:
Income from continuing operations	$	52,305		$	9,093
Non-controlling interests’ share in continuing operations		(130	)		(131	)
Participating securities’ share in earnings		(715	)		(860	)

Income from continuing operations, less participating securities’ share in earnings		51,460			8,102
Income from discontinued operations attributable to MPT Operating Partnership partners		9,169			4,944

Net income, less participating securities’ share in earnings	$	60,629		$	13,046


Denominator
Basic weighted-average units		131,467			110,568
Dilutive options		—			8

Dilutive weighted-average units		131,467			110,576

For the three and nine months ended September 30, 2012 and 2011, 0.1 million of options were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive. Shares/units that may be issued in the future in accordance with our exchangeable senior notes were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive.

10. Contingencies

We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

11. Subsequent Events

In October 2012, we agreed to fund the construction of an inpatient rehabilitation hospital in Spartanburg, SC that will be operated by Ernest. The estimated cost for the development is $18 million, and the construction is expected to be completed by the third quarter of 2013.

12. Condensed Consolidating Financial Information

The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. (“Parent” and a guarantor to our 2011 and 2012 Senior Unsecured Notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation (“Subsidiary Issuer”), (c) on a combined basis, the guarantors of our 2011 and 2012 Senior Unsecured Notes (“Subsidiary Guarantors”), and (d) on a combined basis, the non-guarantor subsidiaries (“Non-Guarantor Subsidiaries”). Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is joint and several, and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent’s ability to obtain funds from its subsidiaries by dividend or loan.

The guarantees by the Subsidiary Guarantors may be released and discharged upon: (1) any sale, exchange or transfer of all of the capital stock of a Subsidiary Guarantor; (2) the merger or consolidation of a Subsidiary Guarantor with a Subsidiary Issuer or any other Subsidiary Guarantor; (3) the proper designation of any Subsidiary Guarantor by the Subsidiary Issuers as “unrestricted” for covenant purposes under the indenture governing the 2011 and 2012 Senior Unsecured Notes; (4) the legal defeasance or covenant defeasance or satisfaction and discharge of the indenture; (5) a liquidation or dissolution of a Subsidiary Guarantor permitted under the indenture governing the 2011 and 2012 Senior Unsecured Notes; or (6) the release or discharge of the Subsidiary Guarantor from its guarantee obligations under our revolving credit facility.

Subsequent to December 31, 2011, certain of our subsidiaries were re-designated as guarantors of our 2011 and 2012 Senior Unsecured Notes (such subsidiaries were non-guarantors in 2011), while other subsidiaries have been re-designated as non-guarantors as the underlying properties were sold in 2012 (such subsidiaries were guarantors during 2011). With these re-designations, we have restated the 2011 condensed consolidating financial information below to reflect these changes.

Condensed Consolidated Balance Sheet

September 30, 2012

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	42	$	1,185,920		$	65,947		$	—		$	1,251,909
Real estate held for sale		—		—		17,432			—			—			17,432
Mortgage loans		—		—		268,650			100,000			—			368,650
Net investment in direct financing leases		—		—		110,000			202,050			—			312,050

Gross investment in real estate assets		—		42		1,582,002			367,997			—			1,950,041
Accumulated depreciation and amortization		—		—		(114,188	)		(6,027	)		—			(120,215	)

Net investment in real estate assets				42		1,467,814			361,970			—			1,829,826
Cash & cash equivalents		—		34,371		1,565			227			—			36,163
Interest and rent receivable		—		540		27,881			13,673			—			42,094
Straight-line rent receivable		—		—		31,882			6,183			—			38,065
Other loans		—		176		—			158,001			—			158,177
Net intercompany receivable (payable)		26,750		1,410,629		(1,039,740	)		(397,639	)		—			—
Investment in subsidiaries		1,033,548		602,443		43,693			—			(1,679,684	)		—
Other assets		—		32,330		1,148			20,596			—			54,074

Total Assets	$	1,060,298	$	2,080,531	$	534,243		$	163,011		$	(1,679,684	)	$	2,158,399

Liabilities and Equity
Liabilities
Debt, net	$	—	$	1,010,925	$	—		$	14,258		$	—		$	1,025,183
Accounts payable and accrued expenses		27,140		35,958		731			468			—			64,297
Deferred revenue		—		100		18,796			1,478			—			20,374
Lease deposits and other obligations to tenants		—		—		14,372			1,015			—			15,387

Total liabilities		27,140		1,046,983		33,899			17,219			—			1,125,241
Total equity		1,033,158		1,033,548		500,344			145,792			(1,679,684	)		1,033,158

Total Liabilities and Equity	$	1,060,298	$	2,080,531	$	534,243		$	163,011		$	(1,679,684	)	$	2,158,399

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	29,256	$	4,162		$	(2,335	)	$	31,083
Straight-line rent		—			—			2,387		375			—			2,762
Income from direct financing leases		—			—			5,238		5,394			(4,859	)		5,773
Interest and fee income		—			5,242			8,917		6,943			(7,065	)		14,037

Total revenues		—			5,242			45,798		16,874			(14,259	)		53,655
Expenses
Real estate depreciation and amortization		—			—			8,066		425			—			8,491
Property-related		—			88			121		7,203			(7,194	)		218
General and administrative		—			6,332			—		720			—			7,052
Acquisition expenses		—			410			—		—			—			410

Total operating expenses		—			6,830			8,187		8,348			(7,194	)		16,171

Operating income (expense)		—			(1,588	)		37,611		8,526			(7,065	)		37,484
Other income (expense)
Interest and other income (expense)		—			(21	)		—		(2	)		—			(23	)
Earnings from equity and other interests		—			—			330		735			—			1,065
Interest expense		—			(15,203	)		389		(7,297	)		7,065			(15,046	)

Net other income (expense)		—			(15,224	)		719		(6,564	)		7,065			(14,004	)

Income (loss) from continuing operations		—			(16,812	)		38,330		1,962			—			23,480
Income (loss) from discontinued operations		—			—			1,069		6,959			—			8,028
Equity in earnings of consolidated subsidiaries net of income taxes		31,508			48,320			1,129		—			(80,957	)		—

Net income (loss)		31,508			31,508			40,528		8,921			(80,957	)		31,508
Net income (loss) attributable to non-controlling interests		(44	)		(44	)		—		—			44			(44	)

Net income (loss) attributable to MPT common stockholders	$	31,464		$	31,464		$	40,528	$	8,921		$	(80,913	)	$	31,464

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	87,579		$	12,447		$	(6,926	)	$	93,100
Straight-line rent		—			—			4,354			1,119			—			5,473
Income from direct financing leases		—			—			11,730			12,600			(11,351	)		12,979
Interest and fee income		—			13,219			20,621			17,357			(17,711	)		33,486

Total revenues		—			13,219			124,284			43,523			(35,988	)		145,038
Expenses
Real estate depreciation and amortization		—			—			24,117			1,275			—			25,392
Property-related		—			349			597			18,375			(18,277	)		1,044
General and administrative		—			20,067			—			1,274			—			21,341
Acquisition expenses		—			4,115			—			—			—			4,115

Total operating expenses		—			24,531			24,714			20,924			(18,277	)		51,892

Operating income (expense)		—			(11,312	)		99,570			22,599			(17,711	)		93,146
Other income (expense)
Interest and other income (expense)		—			(49	)		(2	)		(4	)		—			(55	)
Earnings from equity and other interests		—			—			783			1,161			—			1,944
Interest expense		—			(42,905	)		867			(18,403	)		17,711			(42,730	)

Net other income (expense)		—			(42,954	)		1,648			(17,246	)		17,711			(40,841	)

Income (loss) from continuing operations		—			(54,266	)		101,218			5,353			—			52,305
Income (loss) from discontinued operations		—			—			2,363			6,806			—			9,169
Equity in earnings of consolidated subsidiaries net of income taxes		61,474			115,740			3,367			—			(180,581	)		—

Net income (loss)		61,474			61,474			106,948			12,159			(180,581	)		61,474
Net income (loss) attributable to non-controlling interests		(130	)		(130	)		—			—			130			(130	)

Net income (loss) attributable to MPT common stockholders	$	61,344		$	61,344		$	106,948		$	12,159		$	(180,451	)	$	61,344

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Three Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	31,508		$	31,508		$	40,528	$	8,921	$	(80,957	)	$	31,508
Other comprehensive income:
Unrealized loss on interest rate swap		(443	)		(443	)		—		—		443			(443	)

Total comprehensive income		31,065			31,065			40,528		8,921		(80,514	)		31,065
Comprehensive income attributable to non-controlling interests		(44	)		(44	)		—		—		44			(44	)

Comprehensive income attributable to MPT common stockholders	$	31,021		$	31,021		$	40,528	$	8,921	$	(80,470	)	$	31,021

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	61,474		$	61,474		$	106,948	$	12,159	$	(180,581	)	$	61,474
Other comprehensive income:
Unrealized loss on interest rate swap		(989	)		(989	)		—		—		989			(989	)

Total comprehensive income		60,485			60,485			106,948		12,159		(179,592	)		60,485
Comprehensive income attributable to non-controlling interests		(130	)		(130	)		—		—		130			(130	)

Comprehensive income attributable to MPT common stockholders	$	60,355		$	60,355		$	106,948	$	12,159	$	(179,462	)	$	60,355

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2012

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	16		$	(38,780	)	$	114,073		$	(600	)	$	—		$	74,709
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(410,000	)		(196,500	)		—			(606,500	)
Principal received on loans receivable		—			—			5,491			4,016			—			9,507
Net proceeds from sales of real estate		—			—			800			33,300			—			34,100
Investments in and advances to subsidiaries		(143,554	)		(540,016	)		377,472			162,560			143,538			—
Investments in loans receivable		—			—			—			(1,293	)		—			(1,293	)
Construction in progress and other		—			(59	)		(34,349	)		(1,512	)		—			(35,920	)

Net cash provided by (used in) investing activities		(143,554	)		(540,075	)		(60,586	)		571			143,538			(600,106	)
Financing Activities
Revolving credit facilities, net		—			75,000			(39,600	)		—			—			35,400
Additions to term debt		—			300,000			—			—			—			300,000
Payments of term debt		—			—			—			(171	)		—			(171	)
Distributions paid		(76,569	)		(76,770	)		—			—			76,569			(76,770	)
Sale of common stock, net		220,107			220,107			—			—			(220,107	)		220,107
Lease deposits and other obligations to tenants		—			—			(13,731	)		340			—			(13,391	)
Debt issuance costs paid and other financing activities		—			(6,341	)		—			—			—			(6,341	)

Net cash provided by (used in) financing activities		143,538			511,996			(53,331	)		169			(143,538	)		458,834

Increase in cash and cash equivalents for period		—			(66,859	)		156			140			—			(66,563	)
Cash and cash equivalents at beginning of period		—			101,230			1,409			87			—			102,726

Cash and cash equivalents at end of period	$	—		$	34,371		$	1,565		$	227		$	—		$	36,163

Condensed Consolidated Balance Sheet

December 31, 2011

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	37	$	1,151,574		$	65,948		$	—		$	1,217,559
Real estate held for sale		—		—		22,008			26,917			—			48,925
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		37		1,338,582			92,865			—			1,431,484
Accumulated depreciation and amortization		—		—		(90,072	)		(4,750	)		—			(94,822	)

Net investment in real estate assets		—		37		1,248,510			88,115			—			1,336,662
Cash & cash equivalents		—		101,230		1,409			87			—			102,726
Interest and rent receivable		—		399		22,528			6,935			—			29,862
Straight-line rent receivable		—		—		27,388			6,605			—			33,993
Other loans		—		178		5,491			69,170			—			74,839
Net intercompany receivable (payable)		21,955		872,380		(862,281	)		(32,054	)		—			—
Investment in subsidiaries		829,205		489,858		43,008			—			(1,362,071	)		—
Other assets		—		27,285		2,151			14,356			—			43,792

Total Assets	$	851,160	$	1,491,367	$	488,204		$	153,214		$	(1,362,071	)	$	1,621,874

Liabilities and Equity
Liabilities
Debt, net	$	—	$	635,820	$	39,600		$	14,429		$	—		$	689,849
Accounts payable and accrued expenses		22,345		25,783		2,578			419			—			51,125
Deferred revenue		—		559		21,372			1,376			—			23,307
Lease deposits and other obligations to tenants		—		—		28,103			675			—			28,778

Total liabilities		22,345		662,162		91,653			16,899			—			793,059
Total equity		828,815		829,205		396,551			136,315			(1,362,071	)		828,815

Total Liabilities and Equity	$	851,160	$	1,491,367	$	488,204		$	153,214		$	(1,362,071	)	$	1,621,874

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	25,903	$	2,188		$	(331	)	$	27,760
Straight-line rent		—			—			1,219		424			—			1,643
Interest and fee income		—			1,351			4,146		920			(1,188	)		5,229

Total revenues		—			1,351			31,268		3,532			(1,519	)		34,632
Expenses
Real estate depreciation and amortization		—			—			7,212		488			—			7,700
Property-related		—			87			171		333			(331	)		260
General and administrative		18			6,348			—		(629	)		—			5,737
Acquisition expenses		—			513			469		(452	)		—			530

Total operating expenses		18			6,948			7,852		(260	)		(331	)		14,227

Operating income (loss)		(18	)		(5,597	)		23,416		3,792			(1,188	)		20,405
Other income (expense)
Interest and other income (expense)		—			44			—		(2	)		—			42
Earnings from equity and other interests		—			—			84		(75	)		—			9
Debt refinancing costs		—			(10,425	)		—		—			—			(10,425	)
Interest expense		—			(11,735	)		63		(1,451	)		1,188			(11,935	)

Net other income (expense)		—			(22,116	)		147		(1,528	)		1,188			(22,309	)

Income (loss) from continuing operations		(18	)		(27,713	)		23,563		2,264			—			(1,904	)
Income (loss) from discontinued operations		—			—			787		1,585			—			2,372
Equity in earnings of consolidated subsidiaries net of income taxes		486			28,199			1,112		—			(29,797	)		—

Net income (loss)		468			486			25,462		3,849			(29,797	)		468
Net income (loss) attributable to non-controlling interests		(43	)		(43	)		—		—			43			(43	)

Net income attributable to MPT common stockholders	$	425		$	443		$	25,462	$	3,849		$	(29,754	)	$	425

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	76,284		$	5,796		$	(994	)	$	81,086
Straight-line rent		—			—			3,974			1,344			—			5,318
Interest and fee income		—			4,118			13,087			2,597			(4,088	)		15,714

Total revenues		—			4,118			93,345			9,737			(5,082	)		102,118
Expenses
Real estate depreciation and amortization		—			—			21,216			1,292			—			22,508
Property-related		—			87			213			1,040			(994	)		346
General and administrative		62			18,356			—			2,011			—			20,429
Acquisition expenses		—			2,717			469			—			—			3,186

Total operating expenses		62			21,160			21,898			4,343			(994	)		46,469

Operating income (loss)		(62	)		(17,042	)		71,447			5,394			(4,088	)		55,649
Other income (expense)
Interest income and other		—			42			2			(56	)		—			(12	)
Earnings from equity and other interests		—			—			84			(14	)		—			70
Debt refinancing costs		—			(14,109	)		(105	)		—			—			(14,214	)
Interest expense		—			(31,750	)		(31	)		(4,769	)		4,088			(32,462	)

Net other income (expense)		—			(45,817	)		(50	)		(4,839	)		4,088			(46,618	)

Income (loss) from continuing operations		(62	)		(62,859	)		71,397			555			—			9,031
Income (loss) from discontinued operations		—			—			263			4,681			—			4,944
Equity in earnings of consolidated subsidiaries net of income taxes		14,037			76,896			3,457			—			(94,390	)		—

Net income (loss)		13,975			14,037			75,117			5,236			(94,390	)		13,975
Net income (loss) attributable to non-controlling interests		(131	)		(131	)		—			—			131			(131	)

Net income attributable to MPT common stockholders	$	13,844		$	13,906		$	75,117		$	5,236		$	(94,259	)	$	13,844

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Three Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income (loss)	$	468		$	486		$	25,462	$	3,849	$	(29,797	)	$	468
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(5,272	)		(5,272	)		—		—		5,272			(5,272	)

Total comprehensive income (loss)		(4,804	)		(4,786	)		25,462		3,849		(24,525	)		(4,804	)
Comprehensive income attributable to non-controlling interests		(43	)		(43	)		—		—		43			(43	)


Comprehensive income (loss) attributable to MPT common stockholders	$	(4,847	)	$	(4,829	)	$	25,462	$	3,849	$	(24,482	)	$	(4,847	)

Condensed Consolidated Statements of Comprehensive Income (Loss)

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries		Eliminations			Total Consolidated
Net income	$	13,975		$	14,037		$	75,117	$	5,236	$	(94,390	)	$	13,975
Other comprehensive income:
Unrealized loss on interest rate swap		(8,341	)		(8,341	)		—		—		8,341			(8,341	)

Total comprehensive income		5,634			5,696			75,117		5,236		(86,049	)		5,634
Comprehensive income attributable to non-controlling interests		(131	)		(131	)		—		—		131			(131	)

Comprehensive income attributable to MPT common stockholders	$	5,503		$	5,565		$	75,117	$	5,236	$	(85,918	)	$	5,503

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations		Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(124	)	$	(26,727	)	$	86,364		$	7,615		$	—	$	67,128
Investing Activities
Cash paid for acquisitions and other related investments		—			—			(191,625	)		(17,288	)		—		(208,913	)
Principal received on loans receivable		—			—			—